Delivery Order SPE2DB20D3101-SPE2DB25FRSY1
- Not listed
- The Defense Logistics Agency awarded a $1,529.88 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count packages) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The award was competitively procured with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,647.26 to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 mg tablets (60-unit count). This firm fixed price, competitively awarded contract was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60 count) on August 4, 2025, with a ceiling value of $40,373.44. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 MG tablets (60-count packages) valued at $2,931.72. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by July 29, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $4,256.00 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count supply) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,801.61 for 60-count tablets of MULTAQ 400 mg, a pharmaceutical product used in cardiac arrhythmia management. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizing firm fixed price terms. This delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,297.85 to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 MG tablets (60-count units). This firm fixed price contract, with an ultimate completion date of August 4, 2025, was competitively awarded without set-aside designation. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $3,241.33. This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation. AmerisourceBergen, a...
- This is a $7,592.10 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, with an ultimate completion date of June 6, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a $13,456.14 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of July 31, 2024 and does not have a set-aside designation. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRSY1Delivery Order
This delivery order, valued at $7,310.52, awards AmerisourceBergen Drug Corp the supply of MULTAQ 400 mg tablets (60-count units) under a firm fixed-price contract with the Defense Logistics Agency. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and represents a competitive, non-set-aside procurement. The product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive pharmaceutical support globally, enabling the contractor to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare systems, the Defense Health Agency, the U.S. Coast Guard, and other federal healthcare organizations. AmerisourceBergen's consistent success in winning competitive federal pharmaceutical awards demonstrates its capability to meet stringent federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 8/18/25 |